STOCK TITAN

Celcuity (CELC) Stock News, Aug-Nov 2023

CELC NASDAQ

Celcuity Inc. develops targeted oncology therapies as a clinical-stage biotechnology company, with news centered on gedatolisib, an investigational pan-PI3K/mTORC1/2 inhibitor for solid tumors. Company updates frequently cover Phase 3 VIKTORIA-1 data in HR+/HER2- advanced breast cancer, including PIK3CA wild-type and mutant cohorts and combination regimens with fulvestrant and palbociclib.

Recurring announcements also address FDA regulatory submissions and review status for gedatolisib, publications and medical-meeting presentations, quarterly financial results, corporate updates, investor conference participation, and board governance changes.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.48%
Tags
conferences
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.11%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.12%
Tags
conferences earnings date
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.35%
Tags
conferences
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.38%
Tags
private placement
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.79%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.53%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.53%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.10%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.81%
Tags
conferences earnings date

FAQ

What is the current stock price of Celcuity (CELC)?

Celcuity (CELC) last closed at $53.35.

What is the market cap of Celcuity (CELC)?

The market cap of Celcuity (CELC) is approximately $2.6B.